Loading...
OTCMGCAN
Market cap321kUSD
Dec 26, Last price  
0.00USD
1D
-20.00%
1Q
-33.33%
IPO
-99.89%
Name

Greater Cannabis Company Inc

Chart & Performance

D1W1MN
OTCM:GCAN chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
90.67%
Rev. gr., 5y
-68.38%
Revenues
0k
0020995,3757,12048,04412,63000
Net income
-188k
L-65.34%
-3,210-103,000-793,567-839,070-2,147,861-2,578,709-509,809-543,501-188,402
CFO
-103k
L-4.02%
-21004,670-100,109-285,229-289,627-235,433-107,490-103,171

Profile

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
IPO date
Jul 09, 2018
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13
-73.71%
Cost of revenue
5
172
164
Unusual Expense (Income)
NOPBT
(5)
(172)
(151)
NOPBT Margin
Operating Taxes
183
(92)
Tax Rate
NOPAT
(5)
(355)
(59)
Net income
(188)
-65.34%
(544)
6.61%
(510)
-80.23%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
431
503
629
Long-term debt
Deferred revenue
Other long-term liabilities
520
Net debt
265
233
252
Cash flow
Cash from operating activities
(103)
(107)
(235)
CAPEX
Cash from investing activities
Cash from financing activities
500
FCF
178
(303)
(76)
Balance
Cash
167
270
378
Long term investments
Excess cash
167
270
377
Stockholders' equity
(3,668)
(3,551)
(3,415)
Invested Capital
3,438
3,510
3,575
ROIC
ROCE
2.18%
415.61%
EV
Common stock shares outstanding
755,155
587,775
489,503
Price
0.00
56.36%
0.00
-82.26%
0.00
3.33%
Market cap
649
100.89%
323
-78.70%
1,517
248.04%
EV
923
566
1,778
EBITDA
(167)
(146)
EV/EBITDA
Interest
13
123
287
Interest/NOPBT